Levemir Approval History

• FDA approved: Yes (First approved June 16th, 2005)
• Brand name: Levemir
• Generic name: insulin detemir
• Company: Novo Nordisk Inc.
• Treatment for: Diabetes, Type 1, Diabetes, Type 2

Levemir (insulin detemir) is a novel, long- acting form of insulin that provides up to a 24-hour duration of action for the treatment of diabetes mellitus (type 1 and type 2).

FDA Approval History for Levemir

Date	Article
May 22, 2012	FDA Approves Levemir for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
Apr  2, 2012	FDA Approves Levemir Pregnancy Category Change for Women with Diabetes
Jun 16, 2005	Levemir Novo Nordisk Inc. - Treatment for Diabetes Mellitus (Type 1 and Type 2)

See also...

Levemir (insulin detemir ) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.